Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Integrated Transcriptomic Analysis Reveals Coordinated Gliovascular Remodeling Across Diffuse Glioma Grades
AuthorsJuliAnne E. Allgood; Kaitlyn Miller; Lindsey Burnsed; Jessica E. Pullan
Affiliations1. College of Osteopathic Medicine, Rocky Vista University, Ivins, UT 84738, USA; 2. Department of Chemistry and Physics, Southern Utah University, Cedar City, UT 84720, USA
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy
AuthorsLinda Bartalini; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Angela Lamarca; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Jeroen Dekervel; Chiara Braconi; David James Pinato; Emiliano Tamburini; Chiara Carlotta Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Yung-Yeh Su; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Andrea Pretta; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Lorenzo Fornaro; Andrea Casadei-Gardini; Lorenza Rimassa
Affiliations1. Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; 2. IRCCS San Raffaele Hospital, 20132 Milan, Italy; 3. Vita-Salute San Raffaele University, 20132 Milan, Italy; 4. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Japan; 5. Department of Internal Medicine, Mayo Clinic, Phoenix, AZ 85054, USA; 6. Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy; 7. Clinical Oncology Unit, Careggi University Hospital, 50134 Florence, Italy; 8. Department of Experimental and Clinical Medicine, University of Florence, 50139 Florence, Italy; 9. Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam 13620, Republic of Korea; 10. Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology, Hannover Medical School, 30625 Hannover, Germany; 11. Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Schwartz Reisman Liver Research Centre, Toronto ON M5G 2C4, Canada; 12. Department of Medical Oncology, FJD Comprehensive Cancer Centre, ENETS Centre of Excellence (GEP and Lung)—Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain; 13. Fundación Jiménez Díaz University Hospital, Health Research Institute Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), 28040 Madrid, Spain; 14. Oncology 1 Unit, Department of Medical Oncology, Veneto Institute of Oncology IOV—IRCCS, 35128 Padua, Italy; 15. Hepatopancreatobiliary Oncology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy; 16. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56124 Pisa, Italy; 17. Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy; 18. Digestive Oncology, University Hospitals Leuven, 3000 Leuven, Belgium; 19. School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK; 20. Beatson West of Scotland Centre, Glasgow G12 0YN, UK; 21. CRUK Scotland Centre, Glasgow G61 1BD, UK; 22. Department of Surgery&Cancer, Imperial College London, Hammersmith Hospital, London W12 0NN, UK; 23. Department of Oncology and Palliative Care, Cardinale G. Panico, Tricase City Hospital, 73039 Tricase, Italy; 24. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; 25. Santa Maria Delle Croci Hospital of Ravenna, AUSL Romagna, 48121 Ravenna, Italy; 26. Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy; 27. Upper Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, 08035 Barcelona, Spain; 28. UOC Oncologia A, Department of Hematology, Oncology and Dermatology, Policlinico Umberto I, Sapienza University of Rome, 04019 Rome, Italy; 29. Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica Delle Marche, Azienda Ospedaliero-Universitaria Delle Marche, 60126 Ancona, Italy; 30. Digestive Unit, Champalimaud Clinical Centre, Champalimaud Research Centre Champalimaud Foundation, 1400-038 Lisbon, Portugal; 31. Division of Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea; 32. Department of Medical Oncology, OECI Comprehensive Cancer Centre—ENETS Centre of Excellence (GEP and Lung)—Fundacion Jimenez Diaz University Hospital, Health Research Institute Fundación Jiménez Díaz (IIS-FJD), 28040 Madrid, Spain; 33. Medical Oncology and Biomedical Therapy, Policlinico Riuniti, 71122 Foggia, Italy; 34. Medical Clinic 1, University Hospital, Goethe-University Frankfurt, 60590 Frankfurt am Main, Germany; 35. Dipartimento di Oncologia medica, Fondazione Poliambulanza, 25124 Brescia, Italy; 36. Clinical Experimental Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, 80131 Naples, Italy; 37. IRCCS Istituto Nazionale Tumori Regina Elena, 00138 Roma, Italy; 38. Internal Medicine 1, University Hospital Ulm, 89081 Ulm, Germany; 39. Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, 89081 Ulm, Germany; 40. Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Republic of Korea; 41. Oncologia Medica, Dipartimento di Medicina dei Sistemi, Università di Tor Vergata, 00133 Roma, Italy; 42. Department of Medical Oncology, Unidade Local de Saude do Algarve (ULSAlg), 8000-286 Faro, Portugal; 43. Medical Oncology Unit, University Hospital of Parma, Parma 43126, Italy; 44. Oncology Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy; 45. Department of Internal Medicine and Medical Therapy, University of Pavia, 27100 Pavia, Italy; 46. Division of Medical Oncology, Candiolo Cancer Institute IRCCS, 10060 Turin, Italy; 47. Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, 10043 Turin, Italy; 48. Medical Oncology, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy; 49. Oncology Unit, Ospedale del Mare, 80147 Napoli, Italy; 50. ASAN Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea; 51. Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, 01100 Viterbo, Italy; 52. Oncology Unit, Fondazione IRCCS “Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy; 53. Medical Oncology, University Hospital and University of Cagliari, 09042 Cagliari, Italy; 54. GI Oncology Unit and Familial Cancer Unit, Oncology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain; 55. Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; 56. Department of Medicine I, Clinical Division of Oncology, Medical University Vienna, 1090 Vienna, Austria; 57. Department of Medical Oncology, AULSS 8 Berica, 36110 Vicenza, Italy; 58. UOC Oncologia Territoriale, Polo Pontino, La Sapienza Università Di Roma, 04100 Latina, Italy; 59. National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan; 60. Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan; 61. Department of Clinical Oncology, Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong SAR, China; 62. Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK; 63. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy
IL1β Functions as a Tumor Suppressor in Papillary Thyroid Carcinoma via the SMDT1-MAPK Signaling Axis
AuthorsTenghong Liu; Liyong Zhang; Zhijun Chen; Shaojun Cai; Wenxin Zhao
Affiliations1. Department of Thyroid Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China
Impact of 18F-DCFPyL-PSMA PET/CT on Radiotherapy Planning and Treatment Intensification in Occult Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
AuthorsFrancesco Amorelli; Pedro Plaza; Augusto Natali; Juan Sebastian Blanco; Xavier Duran; Palmira Foro
Affiliations1. Department of Radiation Oncology, Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, 08908 Barcelona, Spain; 2. Ph.D. Program, Doctoral School, Pompeu Fabra University, 08002 Barcelona, Spain; 3. Department of Nuclear Medicine, Hospital del Mar, 08003 Barcelona, Spain; 4. Department of Laboratory Medicine, CLILAB Diagnostics, Hospitalet de Llobregat, 08906 Barcelona, Spain; 5. Medical Statistics Unit (MSU) MARData, Hospital del Mar, 08003 Barcelona, Spain; 6. Department of Radiation Oncology, Hospital del Mar, 08003 Barcelona, Spain
Clinical and Radiologic Features Correlated with Eye-Sparing Surgery vs. Orbital Exenteration for Lacrimal Gland Adenoid Cystic Carcinoma †
AuthorsBita Esmaeli; Yunyi Wang; Tracy Lu; Jing Ning; Amy C. Moreno; Steven J. Frank; Luana G. Sousa; Renata Ferrarotto; J. Matthew Debnam
Affiliations1. Department of Ophthalmology, Houston Methodist Hospital Academic Institute, Houston, TX 77030, USA; 2. Oncologic Ophthalmic Plastic & Orbital Surgery, Mann Eye Institute, Houston, TX 77004, USA; 3. Department of Clinical Sciences, University of Houston Tilman J. Fertitta Family College of Medicine, Houston, TX 77001, USA; 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 5. Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 6. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 7. Department of Head and Neck & Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 8. Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Line-Field Confocal Optical Coherence Tomography as a Follow-Up Tool for 3D-Printed HDR Surface Brachytherapy of Cutaneous Squamous Cell Carcinoma: A Proof-of-Concept Study at Short-Term (Six-Month) Follow-Up
AuthorsPiotr Sobolewski; Mateusz Koper; Michal Poltorak; Pawel Banatkiewicz; Malgorzata Kolos; Lukasz Poltorak; Maciej Szwast; Irena Walecka
Affiliations1. The National Medical Institute of the Ministry of the Interior and Administration, Woloska 137, 02-507 Warsaw, Poland; 2. Chair and Clinic of Dermatology and Pediatric Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland; 3. Electrochemistry at Soft Interfaces Team, Department of Inorganic and Analytical Chemistry, Faculty of Chemistry, University of Lodz, Tamka 12, 91-403 Lodz, Poland; 4. Department of Chemical and Process Engineering, Warsaw University of Technology, Warynskiego 1, 00-645 Warsaw, Poland
Changes in C-Reactive Protein Forecast Infection Risk Following Treatment with Chimeric Antigen Receptor T Cells
AuthorsPoonam Mathur; Hegang Chen; David J. Riedel; Elizabeth Holland; Danica Palacio; Jacqueline T. Bork; Katya Prakash; Nancy Hardy; Mehmet Kocoglu; Ashraf Badros; Ariel Fromowitz; Jean Yared; Aaron P. Rapoport; Djordje Atanackovic; John Baddley
Affiliations1. Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; 3. Zucker School of Medicine, Northwell Health, Manhasset, NY 11030, USA; 4. University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, USA; 5. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
First-Line Immune Checkpoint Inhibitors in Older Patients with Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis
AuthorsDalila Incognito; Andrea D’Arienzo; Sergio Facchini; Chiara Barraco; Antonio Picone; Antonella Nicastro; Giuliana Ciappina; Giordana Di Mauro; Antonio Ieni; Massimiliano Berretta; Gaetano Facchini
Affiliations1. Medical Oncology Unit, Department of Human Pathology “G. Barresi”, School of Specialization in Medical Oncology, University of Messina, 98122 Messina, Italy; 2. Translational Molecular Medicine and Surgery, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; 3. Oncology Unit, “Santa Maria Delle Grazie” Hospital, 80078 Pozzuoli, Italy; 4. Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy; 5. Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; 6. Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy; 7. Applied Biology and Experimental Medicine, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy; 8. Department of Human Pathology of Adult and Childhood “Gaetano Barresi”, University of Messina, 98121 Messina, Italy; 9. Division of Medical Oncology, “G. Martino” University Hospital, University of Messina, 98124 Messina, Italy
SBRT for Colorectal Cancer Liver Metastasis Is a Safe and Effective Treatment Option—A Single Institution Retrospective Analysis
AuthorsNitsan Peled Oved; Marc Wygoda; Adi Levy; Mor Oved; Philip Blumenfeld; Ayala Hubert; Aron Popovtzer; Tamar Peretz; Aviad Zick; Tal Falick Michaeli
Affiliations1. Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel; 2. Department of Military Medicine and “Tzamert”, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel; 3. Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel
Functionally Informed Hand Knob Reveals Structural Connectome Differences in Motor-Eloquent Tumours
AuthorsSankhya Prakashvel; Filippo Sinosi; Laura Ferrari; Feras Fayez; Sabina Patel; Yasir A. Chowdhury; Andrea Perera; Nida Kalyal; Mariam Awan; Alba Diaz-Baamonde; Ana Mirallave-Pescador; Keyoumars Ashkan; Ranjeev Bhangoo; Francesco Vergani; Jose Pedro Lavrador
Affiliations1. Queens’ Hospital Romford, London RM7 0AG, UK; 2. King’s College Hospital, London SE5 9RS, UK; 3. University College London Hospital, London NW1 2BU, UK
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
